In this presentation from Lymphoma & Myeloma 2016, Dr. Koen van Besien argues for stem cell transplant-based therapy in the treatment of a limited stage Hodgkin lymphoma patient who remains PET positive at the end of chemotherapy.
Click to Earn CME Credit: http://bit.ly/2mFKBrY
© 2016 Imedex, LLC.
Advertisement